Haemonetics | HAE - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Avanos Medical USD 1.2M 2.4M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cerus USD -20.76M 17.9M 2024-12
Cooper Companies USD 192.2M 75.4M 2025-12
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 340M 168.46M 2026-03
Globus Medical USD 169.23M 25.24M 2025-12
Haemonetics USD 59.97M 8.69M 2025-12
ICU Medical USD -15.9M 86.2M 2025-12
Intuitive Surgical USD 940.4M 15.2M 2026-03
Medtronic USD 2.45B 1.04B 2026-03
Merit Medical Systems USD 51.06M 22.12M 2025-12
Neogen USD 28M 15.81M 2025-09
OraSure Technologies USD -18.43M 5.14M 2025-12
Plus Therapeutics USD -5.71M 1.29M 2025-12
Quidel USD -79.5M 32.9M 2026-03
ResMed USD 496.15M 13.77M 2025-12
STAAR Surgical USD -20.65M 39.44M 2025-12
Steris USD 257.8M 66.6M 2025-12
Stryker USD 1.7B 676M 2025-12
Teleflex USD 218.94M 657.52M 2025-12
Terumo JPY 31.67B 13.71B 2026-03
Thermo Fisher Scientific USD 2.12B 295M 2025-12
US Physical Therapy USD 14.96M 3.82M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12